Boehringer Blood Thinner Linked To Heart Attacks: Study
A new study released Monday found that Boehringer Ingelheim GmbH's Pradaxa carries an increased risk of heart attack compared with other anti-coagulants, spurring at least one plaintiffs' firm to put out...To view the full article, register now.
Already a subscriber? Click here to view full article